Lahiguera, Á., Hyroššová, P., Figueras, A., Garzón, D., Moreno, R., Soto‐Cerrato, V., . . . Viñals, F. (2020). Tumors defective in homologous recombination rely on oxidative metabolism: Relevance to treatments with PARP inhibitors.
Citación estilo ChicagoLahiguera, Álvaro, et al. Tumors Defective in Homologous Recombination Rely On Oxidative Metabolism: Relevance to Treatments With PARP Inhibitors. 2020.
Cita MLALahiguera, Álvaro, et al. Tumors Defective in Homologous Recombination Rely On Oxidative Metabolism: Relevance to Treatments With PARP Inhibitors. 2020.
Precaución: Estas citas no son 100% exactas.